Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc., 61795-61796 [2017-28177]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Network Centric
Operations Industry Consortium, Inc.
Notice is hereby given that, on
December 5, 2017, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Network Centric Operations Industry
Consortium, Inc. (‘‘NCOIC’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Marc Fiammante (individual member),
Alpes Maritimes, FRANCE, has been
added as a party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NCOIC
intends to file additional written
notifications disclosing all changes in
membership.
On November 19, 2004, NCOIC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on February 2, 2005 (70
FR 5486).
The last notification was filed with
the Department on July 11, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on August 15, 2017 (82 FR 38711).
comments on or objections to the
issuance of the proposed registration on
or before February 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
28, 2016, AMPAC Fine Chemicals
Virginia, LLC, 2820 North Normandy
Drive, Petersburg, Virginia 23805–2380
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled
substance
Drug code
Methylphenidate ...
Levomethorphan ...
Levorphanol ..........
1724
9210
9220
Schedule
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–28129 Filed 12–28–17; 8:45 am]
[FR Doc. 2017–28178 Filed 12–28–17; 8:45 am]
BILLING CODE P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
ethrower on DSK3G9T082PROD with NOTICES
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals LLC
Importer of Controlled Substances
Application: ABBVIE LTD; Correction
ACTION:
ACTION:
Notice of application.
VerDate Sep<11>2014
20:09 Dec 28, 2017
Jkt 244001
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register of
December 1, 2017, concerning a notice
SUMMARY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
Notice; correction.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
61795
of application that inadvertently
misstated what the firm plans to do with
imported tapentadol.
Correction
In the Federal Register of December 1,
2017, in FR Doc. 2017–25921 (82 FR
230), on page 230, in the second
column, the last paragraph, correct the
first sentence to read: The company
plans to import bulk tapentadol (9780)
to manufacture dosage form tapentadol
(9780) for distribution to its customers.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–28176 Filed 12–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
High Point, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 27, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 22, 2016, Cambrex High
Point, Inc., 4180 Mendenhall Oaks
Parkway, High Point, North Carolina
27265 applied to be registered as a bulk
DATES:
E:\FR\FM\29DEN1.SGM
29DEN1
61796
Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices
manufacturer of the following basic
classes of controlled substances:
Controlled
substance
Drug code
Oxymorphone .......
Noroxymorphone ..
9652
9668
Schedule
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–28177 Filed 12–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
ethrower on DSK3G9T082PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
To submit
comments:
On December 22, 2017, the
Department of Justice lodged a proposed
Consent Decree with the United States
District Court for the Middle District of
Louisiana in the lawsuit entitled United
States et al. v. Sid Richardson Carbon,
LTD., (M.D. La.), Civil Case. No. 3:17-cv01792–SDD–RLB.
In this civil enforcement action under
the federal Clean Air Act (‘‘Act’’), the
United States, the Louisiana Department
of Environmental Quality, and the State
of Texas allege that Sid Richardson
Carbon, LTD. (‘‘Defendant’’), failed to
comply with certain requirements of the
Act intended to protect air quality at
three carbon black manufacturing
facilities in Addis, Louisiana and Borger
and Big Spring, Texas. The complaint
seeks injunctive relief and civil
penalties for violations of the Clean Air
Act’s Prevention of Significant
Deterioration (‘‘PSD’’) provisions, 42
U.S.C. 7470–92; the Act’s
Nonattainment New Source Review
provisions, 42 U.S.C. 7501–7515; the
Act’s National Emissions Standards for
Hazardous Air Pollutants, 42 U.S.C.
7412; and various Clean Air Act
implementing regulations. The
complaint alleges that Defendant failed
to obtain appropriate permits and failed
to install and operate required pollution
control devices to reduce emissions of
sulfur dioxide (‘‘SO2’’), nitrogen oxides
(‘‘NOX’’), and/or particulate matter
(‘‘PM’’) at the Addis, Borger, and Big
Spring facilities.
The proposed Consent Decree would
resolve violations for certain provisions
of the Act at the three facilities, and
would require the Defendant to reduce
harmful SO2, NOX, and PM emissions
through the installation and operation of
VerDate Sep<11>2014
20:09 Dec 28, 2017
Jkt 244001
pollution controls. The Defendant will
also spend $490,000 to fund
environmental mitigation projects that
will further reduce emissions and
benefit communities adversely affected
by the pollution from the facilities, and
pay a civil penalty of $999,000.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States et al. v. Sid
Richardson Carbon, LTD., (M.D. La.),
D.J. Ref. No. 90–5–2–1–10663. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington,
D.C. 20044–7611.
By mail .........
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.usdoj.gov/enrd/consent-decrees.
The Justice Department will provide a
paper copy of the proposed Consent
Decree upon written request and
payment of reproduction costs. Please
mail your request and payment to:
Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $26.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Thomas P. Carroll,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
States et al. v. Valley Wood Preserving,
Inc., et al., Civil Action No. 1:94–cv–
05984.
This case involves claims under
CERCLA relating to the costs of
remediating soil and groundwater
contamination at the Valley Wood
Preserving Site in Turlock, California
(the ‘‘Site’’). Under the proposed
Consent Decree, Valley Wood
Preserving, Inc. agrees to conduct the
remaining cleanup work at the Site and
to pay EPA’s future response costs
incurred in connection with the Site. In
exchange, Valley Wood Preserving, Inc.
receives a covenant not to sue under
Sections 106 and 107 of CERCLA and
Section 7003 of the Resource
Conservation and Recovery Act
(‘‘RCRA’’). A group of current and
former shareholders and employees of
Valley Wood Preserving, Inc.—Lynn
Shurtliff, Edgar J. Langley, Cordes J.
Langley, Catherine E.L. Elawadly, Edith
E.. Langley, Joyce Logsdon, the Estate of
Michael H. Logsdon, the Marie J.
Langley Revocable Trust, and Robert
Schmidt—are also parties to the
proposed Consent Decree, and also
receive covenants not to sue under
CERCLA and RCRA.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States, et al. v. Valley
Wood Preserving, Inc., et al., D.J. Ref.
No. 90–11–3–835. All comments must
be submitted no later than thirty (30)
days after the publication date of this
notice. Comments may be submitted
either by email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
[FR Doc. 2017–28164 Filed 12–28–17; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’)
On December 21, 2017, the
Department of Justice lodged a proposed
Consent Decree with the United States
District Court for the Eastern District of
California in the lawsuit entitled United
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Under section 7003(d) of RCRA, a
commenter may request an opportunity
for a public meeting in the affected area.
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed Consent Decree upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Pages 61795-61796]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28177]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cambrex
High Point, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 27, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 22, 2016, Cambrex High Point, Inc., 4180 Mendenhall Oaks
Parkway, High Point, North Carolina 27265 applied to be registered as a
bulk
[[Page 61796]]
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Oxymorphone.......................... 9652 II
Noroxymorphone....................... 9668 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for distribution to its customers.
Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-28177 Filed 12-28-17; 8:45 am]
BILLING CODE 4410-09-P
